These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fighting cancer with plant-expressed pharmaceuticals. Pujol M; Gavilondo J; Ayala M; Rodríguez M; González EM; Pérez L Trends Biotechnol; 2007 Oct; 25(10):455-9. PubMed ID: 17869360 [TBL] [Abstract][Full Text] [Related]
4. Pharming and transgenic plants. Liénard D; Sourrouille C; Gomord V; Faye L Biotechnol Annu Rev; 2007; 13():115-47. PubMed ID: 17875476 [TBL] [Abstract][Full Text] [Related]
6. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Gerngross TU Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166 [TBL] [Abstract][Full Text] [Related]
7. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Schähs M; Strasser R; Stadlmann J; Kunert R; Rademacher T; Steinkellner H Plant Biotechnol J; 2007 Sep; 5(5):657-63. PubMed ID: 17678502 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G specifically binding plant N-glycans with high affinity could be generated in rabbits but not in mice. Jin C; Bencúrová M; Borth N; Ferko B; Jensen-Jarolim E; Altmann F; Hantusch B Glycobiology; 2006 Apr; 16(4):349-57. PubMed ID: 16373330 [TBL] [Abstract][Full Text] [Related]
10. Expression of rat beta(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation. Frey AD; Karg SR; Kallio PT Plant Biotechnol J; 2009 Jan; 7(1):33-48. PubMed ID: 18778316 [TBL] [Abstract][Full Text] [Related]
11. Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants. Chen M; Liu X; Wang Z; Song J; Qi Q; Wang PG Med Res Rev; 2005 May; 25(3):343-60. PubMed ID: 15499575 [TBL] [Abstract][Full Text] [Related]
12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
13. Plant cell cultures for the production of recombinant proteins. Hellwig S; Drossard J; Twyman RM; Fischer R Nat Biotechnol; 2004 Nov; 22(11):1415-22. PubMed ID: 15529167 [TBL] [Abstract][Full Text] [Related]
14. Expression systems for therapeutic glycoprotein production. Durocher Y; Butler M Curr Opin Biotechnol; 2009 Dec; 20(6):700-7. PubMed ID: 19889531 [TBL] [Abstract][Full Text] [Related]
15. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Daniell H Biotechnol J; 2006 Oct; 1(10):1071-9. PubMed ID: 17004305 [TBL] [Abstract][Full Text] [Related]
16. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots. Sivakumar G Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730 [TBL] [Abstract][Full Text] [Related]
17. Approaches to achieve high-level heterologous protein production in plants. Streatfield SJ Plant Biotechnol J; 2007 Jan; 5(1):2-15. PubMed ID: 17207252 [TBL] [Abstract][Full Text] [Related]
18. Biopharmaceuticals derived from genetically modified plants. Goldstein DA; Thomas JA QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527 [TBL] [Abstract][Full Text] [Related]
19. Plant glycans: friend or foe in vaccine development? Bosch D; Schots A Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008 [TBL] [Abstract][Full Text] [Related]